| abstract |
The invention discloses a pyridine compound represented by formula (I). The present invention also relates to a pharmaceutical composition containing a compound of formula (I) and the use of the compound in the preparation of an inhibitor of a mutant mutant with IDH function, which can be used for the treatment of cancer, including but not limited to the treatment of leukemia, glioma, multiple Glioblastoma, paraganglioma, supratentorial primitive nerve, ectodermal tumors, acute myeloid leukemia, prostate cancer, thyroid cancer, colon cancer, chondrosarcoma, cholangiocarcinoma, peripheral T-cell lymphoma, and melanoma tumor. |